Table 1.

Characteristics of rivaroxaban users

	Male N = 201	Female N = 224	Total N = 425
Age at cohort entry
Mean (std)	64.2 (10.4)	63.4 (11.6)	63.8 (11.0)
<18 years	0 (0.0 %)	0 (0.0 %)	0 (0.0 %)
18–39 years	2 (1.0 %)	11 (4.9 %)	13 (3.1 %)
40–59 years	65 (32.3 %)	55 (24.6 %)	120 (28.2 %)
60–79 years	123 (61.2 %)	152 (67.9 %)	275 (64.7 %)
≥80 years	11 (5.5 %)	6 (2.7 %)	17 (4.0 %)
Multiple treatment episodes	11 (5.5 %)	4 (1.8 %)	15 (3.5 %)